Arcus Biosciences
D

RCUS

18.530
USD
-0.84
(-4.34%)
قبل الجلسة
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
752
الربح لكل سهم
-4
العائد الربحي
-
P/E
-5
حجم السوق
2,359,487,457
أصول ذات صلة

العنوان: Arcus Biosciences

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.